From: The effect of insulin administration on c-peptide in critically ill patients with type 2 diabetes
Variable | All patients (n = 45) | Non-insulin group (n = 25) | Insulin group (n = 20) | P |
---|---|---|---|---|
Blood glucose level (mmol/l) | ||||
Day 1 | 9.9 (7.0, 11.0) | 7.9 (6.4, 10.0) | 11.0 (9.8, 12.0) | <0.001 |
Day 2 | 9.8 (8.1, 12.0) | 8.7 (6.8, 11.0) | 12.0 (9.7, 16.0) | <0.001 |
Plasma C-peptide level (nmol/l) | ||||
Day 1 | 1.3 (0.8, 2.9) | 1.6 (0.9, 2.3) | 0.9 (0.3, 3.0) | 0.19 |
Day 2 | 1.6 (0.9, 2.3) | 1.7 (1.3, 2.1) | 1.3 (0.6, 3.4) | 0.29 |
Creatinine level (µmol/l) | ||||
Day 1 | 127 (73, 195) | 105 (68, 195) | 138 (91, 189) | 0.55 |
Day 2 | 113 (73, 216) | 92 (61, 216) | 117 (90, 222) | 0.49 |
Ketonemia, n (%)a | ||||
Day 1 | 12/34 (35.3%) | 6/18 (33.3%) | 6/16 (37.5%) | 0.80 |
Day 2 | 11/36 (30.6%) | 8/19 (42.1%) | 3/17 (17.6%) | 0.16 |
Ketonuria, n (%)b | ||||
Day 1 | 3/34 (8.8%) | 0/18 | 3/16 (18.8%) | – |
Day 2 | 3/36 (8.3%) | 2/19 (10.5%) | 1/17 (5.9%) | 1.0 |
Insulin therapy, n (%) | ||||
Before day 1 | 13 (28.9%) | 4 (16.0%) | 9 (45.0%) | 0.049 |
Between day 1 and day 2 | 20 (44.4%) | 0 | 20 (100%) | – |
Total dose in treated, units | – | – | 24 (14, 46) | – |
Any insulin secretagoguec | ||||
Before day 1 | 3 (7) | 1 (4) | 2 (10) | 0.58 |
Between day 1 and day 2 | 7 (16) | 2 (8) | 5 (25) | 0.21 |
Enteral nutrition, n (%)d | ||||
Day 1 | 2 (4.4%) | 1 (4.0%) | 0 | – |
Day 2 | 9 (20.0%) | 6 (24.0%) | 3 (15.0%) | 0.71 |
Parenteral nutrition, n (%)d | ||||
Day 1 | 1 (2.2%) | 0 | 1 (5.0%) | – |
Day 2 | 2 (4.4%) | 1 (4.0%) | 1 (5.0%) | 1.0 |